Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats
Small-molecule inhibitors of prolyl hydroxylase (PHD) enzymes are a novel target for the treatment of anaemia and functional iron deficiency (FID). Other than being orally bioavailable, the differentiation of PHD inhibitors from recombinant human erythropoietin (rhEPO) has not been demonstrated.JNJ-...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2015
|
| 在线阅读: | https://doi.org/10.1111/bph.13188 https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.13188 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|